-The Hindu Of the 112 projects approved between 2008-12, none were completed Bangalore: The Comptroller and Auditor General of India (CAG) has said there is "no indication of that all habitations would have access to safe drinking water anytime in the near future" given the pace of coverage and competition of projects under National Rural Drinking Water Programme is very slow. The CAG report on Local Bodies for the period 2007-12, which was...
More »SEARCH RESULT
Total Matching Records found : 2002
Battle for justice reaches Geneva-Khelen Thokchom
-The Telegraph Imphal: A Manipuri widow's cry for justice rang out during the 23rd session of the UN Human Rights Council this morning, as she questioned gaps in UN Special Rapporteur on extrajudicial, summary or arbitrary executions Christof Heyns's report on the Armed Forces (Special Powers) Act. Neena Ningobam, who represented the Extrajudicial Execution Victim Families' Association, Manipur, of which she is the secretary, and the Asian Legal Resource Centre (ALRC) at...
More »Aruna Roy, social activist and NCPRI member interviewed by Pallavi Polanki
-Firstpost.com After the UPA-II released its self-congratulatory 79-page ‘Report card to the People', National Advisory Council (NAC) member and leading social activist Aruna Roy has come down heavily on the government for its poor performance in the social sector. Roy, an instrumental force behind the Right to Information Act, criticised the government for stalling on essential legislations such as the Food Security Bill, the Land Acquisition Bill and the Lokpal Bill. Roy spoke...
More »‘Government in the dark on status of 13 schemes’ -Nitin Sethi
-The Times of India NEW DELHI: If the dictum 'you can't manage what you can't measure' is true, then the government has an unsure grip over at least half the 13 flagship schemes worth nearly Rs 2 lakh crore annually, almost 80% of the total spend on central schemes. The government is unable to efficiently collate information to assess whether some of the 13 key flagship schemes are producing the results for...
More »Indian pharma's generic challenge-DG Shah
-The Business Standard USFDA's zero tolerance policy requires our drug firms to reorient not just processes but organisational cultures to serve that market credibly The following two quotes from the United States Food and Drug Administration (FDA) news releases may help put the Ranbaxy controversy in perspective. The first sums up what it is that drives the FDA and the second is typical of the challenge the pharmaceutical industry faces. (1) "The consent...
More »
